Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Antidepressant effect in older depressed patients: the lessons of two agomelatine trials

Abstract : The present paper reports in parallel the findings of the two phase III trials that evaluated the efficacy of agomelatine in older depressed patients. It describes how the particular methodological innovations (particularly in relation to patient selection, design and accuracy of diagnosis of depression) introduced in study 2 have improved the quality of recruitment of patients and the assay sensitivity. Study 1 lacked assay sensitivity, and among the many differences with study 2, the inclusion of unexpected mildly ill patients could have inflated the placebo response. The increased demands on investigators in study 2 appear to have reduced the placebo effect and showed a robust benefit of agomelatine. The two agomelatine studies offer the opportunity to discuss hypotheses that have been raised to explain the low level of response of older patients to available antidepressants.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.univ-lille.fr/hal-02351285
Contributeur : Lilloa Université de Lille <>
Soumis le : mercredi 6 novembre 2019 - 12:47:06
Dernière modification le : mardi 3 novembre 2020 - 10:26:01

Identifiants

Collections

Citation

Guy M. Goodwin, Pierre Thomas, Reinhard Heun, Patrice Boyer, Françoise Picarel-Blanchot, et al.. Antidepressant effect in older depressed patients: the lessons of two agomelatine trials. International Clinical Psychopharmacology, 2017, International Clinical Psychopharmacology, 32 (4), pp.184-194. ⟨10.1097/YIC.0000000000000174⟩. ⟨hal-02351285⟩

Partager

Métriques

Consultations de la notice

33